30195-30-3

30195-30-3 structure

Name: Ro 5-3335
Chemical Name: 7-chloro-5-(1H-pyrrol-2-yl)-1,3-dihydro-1,4-benzodiazepin-2-one
CAS Number: 30195-30-3
Molecular Formula: C₁₃H₁₀ClN₃O
Molecular Weight: 259.69100
Catalog: Signaling Pathways Others Others
Create Date: 2016-11-21 18:17:16
Modify Date: 2025-08-25 23:17:30
Ro5-3335, a benzodiazepine, acts as an inhibitor of core binding factor (CBF) leukemia. Ro5-3335 is a RUNX1-CBFβ interaction inhibitor that represses RUNX1/CBFB-dependent transactivation[1].

Name	7-chloro-5-(1H-pyrrol-2-yl)-1,3-dihydro-1,4-benzodiazepin-2-one
Synonyms	2H-1,4-Benzodiazepin-2-one,7-chloro-1,3-dihydro-5-pyrrol-2-yl UNII-DLH4T68L7I Ro 5-3335

Description	Ro5-3335, a benzodiazepine, acts as an inhibitor of core binding factor (CBF) leukemia. Ro5-3335 is a RUNX1-CBFβ interaction inhibitor that represses RUNX1/CBFB-dependent transactivation[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others
Target	RUNX1-CBFβ interaction[1]
In Vitro	Ro5-3335 has antiproliferative activity against human CBF leukemia cell lines, with IC50s of 1.1 μM, 21.7 μM and 17.3 μM for ME-1, Kasumi-1 and REH, respectively[1]. Ro5-3335 inhibits definitive hematopoiesis in zebrafish embryos[1]. Ro5-3335 does not completely break apart RUNX1-CBFβ interaction, but changes the conformation of their complex or increases the distance between RUNX1 and CBFβ in the complex[1].
In Vivo	Ro5-3335 is identified as an inhibitor of RUNX1–CBFβ function in zebrafish models[1]. Ro5-3335 rescues preleukemic phenotype in a RUNX1-ETO transgenic zebrafish[1]. Ro5-3335 (300 mg/kg/d; p.o; for 30 days) reduces leukemia burden in a mouse CBFB-MYH11 leukemia model[1]. Animal Model: C57BL/6 mice (leukemic model)[1] Dosage: 300 mg/kg Administration: Oral administration; daily; for 30 days Result: Reduced the number of c-kit+ cells in the transplanted mice and leukemic cell infiltration in the livers, bone marrow and spleen.
References	[1]. Cunningham L, et al. Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction. Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14592-7.

Density	1.46g/cm3
Boiling Point	501.6ºC at 760mmHg
Melting Point	256 °C (分解)
Molecular Formula	C₁₃H₁₀ClN₃O
Molecular Weight	259.69100
Flash Point	257.1ºC
Exact Mass	259.05100
PSA	57.25000
LogP	2.03120
Index of Refraction	1.712
Storage condition	2-8℃

Hazard Codes	Xi

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

1622-61-3	2011-67-8
40790-04-3	30195-30-3
2640889-36-5	2640818-11-5
2640889-40-1	2640814-27-1
2640964-43-6	2640862-44-6
2640828-57-3	2640895-73-2
2640881-91-8	2640962-43-0